Bioqual Total Liabilities and Share Holders Equity 2010-2024 | BIOQ
Bioqual total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Bioqual Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024 |
$57 |
| 2023 |
$61 |
| 2022 |
$63 |
| 2021 |
$53 |
| 2020 |
$50 |
| 2019 |
$28 |
| 2018 |
$26 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$0 |
Bioqual Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-08-31 |
$54 |
| 2024-05-31 |
$57 |
| 2024-02-29 |
$59 |
| 2023-11-30 |
$59 |
| 2023-08-31 |
$61 |
| 2023-05-31 |
$61 |
| 2023-02-28 |
$62 |
| 2022-11-30 |
$64 |
| 2022-08-31 |
$65 |
| 2022-05-31 |
$63 |
| 2022-02-28 |
$62 |
| 2021-11-30 |
$62 |
| 2021-08-31 |
$54 |
| 2021-05-31 |
$53 |
| 2021-02-28 |
$50 |
| 2020-11-30 |
$51 |
| 2020-08-31 |
$51 |
| 2020-05-31 |
$50 |
| 2020-02-29 |
$48 |
| 2019-11-30 |
$48 |
| 2019-08-31 |
$0 |
| 2019-05-31 |
$28 |
| 2019-02-28 |
$0 |
| 2018-11-30 |
$0 |
| 2018-08-31 |
|
| 2018-05-31 |
$26 |
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
$0 |
| 2009-05-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
